Michael H. Silber

TL;DR: Patients with the coexistence of narcolepsy and another CNS disorder seen between 1975 and 1998 at their institution were identified, andHypothalamic–pituitary pathology was the most common association.

TL;DR: Investigation of structural MRI and digital microscopic characteristics of REM sleep behavior disorder in individuals with low-, intermediate-, and high-likelihood dementia with Lewy bodies at autopsy found presence of pRBD is associated with a higher likelihood of DLB and less severe Alzheimer-related pathology in the medial temporal lobes, whereas absence of p RBD is characterized by Alzheimer-like atrophy patterns on MRI and increased phospho-tau burden.

TL;DR: These ELISA assay results do not support the hypothesis that HLA DQB1*0602-positive narcolepsy with cataplexy is associated with serum antibodies against preprohypocretin or its cleavage products.

TL;DR: This review describes how each symptom may relate to the dementing illnesses themselves, which primary sleep disorders may be at play, which medications employed for dementia may impact on the symptom, the role of depression in that symptom, and how circadian dysrhythmias can underlie that symptom.

TL;DR: A 51-item questionnaire succeeds in identifying cataplexy in narcolepsy-catapLexy patients measured up against a comparison group and could subsequently be included into screening tools for use with different patient populations.